Published in J Antimicrob Chemother on September 03, 2004
A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med (2006) 4.19
High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob Agents Chemother (2006) 1.29
Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India. Antimicrob Agents Chemother (2005) 1.21
Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigellae in India. J Clin Microbiol (2006) 1.16
Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J Health Popul Nutr (2007) 1.16
Genomic analysis of the emergence of 20th century epidemic dysentery. BMC Genomics (2014) 0.97
Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011. Eur J Clin Microbiol Infect Dis (2013) 0.89
Fluoroquinolone resistance mechanisms of Shigella flexneri isolated in Bangladesh. PLoS One (2014) 0.88
Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1. Curr Microbiol (2006) 0.86
Atypical class 1 integron coexists with class 1 and class 2 integrons in multi-drug resistant Shigella flexneri isolates from China. Curr Microbiol (2010) 0.84
The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal. Epidemiol Infect (2006) 0.82
Enhanced resistance to fluoroquinolones in laboratory-grown mutants & clinical isolates of Shigella due to synergism between efflux pump expression & mutations in quinolone resistance determining region. Indian J Med Res (2015) 0.76
Cholera. Lancet (2004) 10.22
Evidence for several waves of global transmission in the seventh cholera pandemic. Nature (2011) 5.62
Comparative genomics reveals mechanism for short-term and long-term clonal transitions in pandemic Vibrio cholerae. Proc Natl Acad Sci U S A (2009) 4.80
New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol (2002) 4.54
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet (2008) 4.35
Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet (2005) 4.16
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet (2009) 3.97
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Evolution of new variants of Vibrio cholerae O1. Trends Microbiol (2009) 3.75
Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains. J Virol (2008) 3.73
Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc Natl Acad Sci U S A (2005) 3.62
Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. J Clin Microbiol (2006) 3.60
Cholera in Mozambique, variant of Vibrio cholerae. Emerg Infect Dis (2004) 3.39
Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariants. Clin Microbiol Rev (2007) 3.36
A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. J Infect Dis (2002) 3.27
Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh. Appl Environ Microbiol (2005) 3.17
Environmental signatures associated with cholera epidemics. Proc Natl Acad Sci U S A (2008) 3.05
5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis (2013) 2.82
Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage. Proc Natl Acad Sci U S A (2005) 2.80
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Genomic diversity of enterohemorrhagic Escherichia coli O157 revealed by whole genome PCR scanning. Proc Natl Acad Sci U S A (2002) 2.70
Reduction of cholera in Bangladeshi villages by simple filtration. Proc Natl Acad Sci U S A (2003) 2.68
Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant of Vibrio cholerae O1 biotype El Tor. Microbiol Immunol (2008) 2.62
Genetic diversity and virulence potential of environmental Vibrio cholerae population in a cholera-endemic area. Proc Natl Acad Sci U S A (2004) 2.59
The burden of cholera in the slums of Kolkata, India: data from a prospective, community based study. Arch Dis Child (2005) 2.59
Hafnia alvei, a probable cause of diarrhea in humans. Infect Immun (1991) 2.55
Transmissibility of cholera: in vivo-formed biofilms and their relationship to infectivity and persistence in the environment. Proc Natl Acad Sci U S A (2006) 2.54
Vibrio cholerae O1 hybrid El Tor strains, Asia and Africa. Emerg Infect Dis (2008) 2.53
Cholera in India: an analysis of reports, 1997-2006. Bull World Health Organ (2010) 2.52
Genome sequence of hybrid Vibrio cholerae O1 MJ-1236, B-33, and CIRS101 and comparative genomics with V. cholerae. J Bacteriol (2010) 2.50
Enterotoxigenic Escherichia coli and Vibrio cholerae diarrhea, Bangladesh, 2004. Emerg Infect Dis (2005) 2.42
Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg Infect Dis (2005) 2.41
Influenza is a major contributor to childhood pneumonia in a tropical developing country. Pediatr Infect Dis J (2010) 2.29
Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol (2009) 2.21
Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review. Abdom Imaging (2013) 2.11
Association between climate variability and hospital visits for non-cholera diarrhoea in Bangladesh: effects and vulnerable groups. Int J Epidemiol (2007) 2.10
BBE02 disruption mutants of Borrelia burgdorferi B31 have a highly transformable, infectious phenotype. Infect Immun (2004) 2.08
RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol (2009) 2.06
Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg (2007) 2.06
Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004. Am J Trop Med Hyg (2006) 2.02
Multidrug-resistant Shigella dysenteriae type 1 in south Asia. Lancet Infect Dis (2003) 1.95
Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Clin Infect Dis (1992) 1.89
Viable but nonculturable Vibrio cholerae O1 in biofilms in the aquatic environment and their role in cholera transmission. Proc Natl Acad Sci U S A (2007) 1.89
Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect Immun (2002) 1.88
Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008. PLoS One (2009) 1.85
Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage. Proc Natl Acad Sci U S A (2007) 1.84
Survival of classic cholera in Bangladesh. Lancet (1991) 1.83
Emergence and evolution of Vibrio cholerae O139. Proc Natl Acad Sci U S A (2003) 1.83
Toxigenic Vibrio cholerae in the aquatic environment of Mathbaria, Bangladesh. Appl Environ Microbiol (2006) 1.81
Nutrition: basis for healthy children and mothers in Bangladesh. J Health Popul Nutr (2008) 1.80
Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother (2009) 1.80
Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun (2005) 1.79
Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates. PLoS Pathog (2010) 1.77
Therapy of travelers' diarrhea with rifaximin on various continents. Am J Gastroenterol (2003) 1.77
Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A (2006) 1.75
Phenotypic and genotypic characterization of serologically atypical strains of Shigella flexneri type 4 isolated in Dhaka, Bangladesh. J Clin Microbiol (2002) 1.74
Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008-2010. Bull World Health Organ (2011) 1.74
Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh. Emerg Infect Dis (2007) 1.73
Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis (2011) 1.73
Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J Biol Chem (1995) 1.72
DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrob Agents Chemother (2002) 1.72
Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia. Emerg Infect Dis (2010) 1.72
Positive effects of multiple pch genes on expression of the locus of enterocyte effacement genes and adherence of enterohaemorrhagic Escherichia coli O157 : H7 to HEp-2 cells. Microbiology (2004) 1.70
Seasonal cholera from multiple small outbreaks, rural Bangladesh. Emerg Infect Dis (2008) 1.70
Prevalence of the pandemic genotype of Vibrio parahaemolyticus in Dhaka, Bangladesh, and significance of its distribution across different serotypes. J Clin Microbiol (2002) 1.70
Silkworm larvae as an animal model of bacterial infection pathogenic to humans. Microb Pathog (2002) 1.69
Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis (2011) 1.69
Engineering epidermal growth factor for enhanced mitogenic potency. Nat Biotechnol (1996) 1.68
Molecular epidemiology of O139 Vibrio cholerae: mutation, lateral gene transfer, and founder flush. Emerg Infect Dis (2003) 1.67
Typhoid fever: a massive, single-point source, multidrug-resistant outbreak in Nepal. Clin Infect Dis (2005) 1.67
Epidemiological, microbiological & electron microscopic study of a cholera outbreak in a Kolkata slum community. Indian J Med Res (2006) 1.66
Seasonal cholera caused by Vibrio cholerae serogroups O1 and O139 in the coastal aquatic environment of Bangladesh. Appl Environ Microbiol (2006) 1.65
Peruvian Vibrio cholerae O1 El Tor strains possess a distinct region in the Vibrio seventh pandemic island-II that differentiates them from the prototype seventh pandemic El Tor strains. J Med Microbiol (2009) 1.64
Role of active efflux in association with target gene mutations in fluoroquinolone resistance in clinical isolates of Vibrio cholerae. Antimicrob Agents Chemother (2002) 1.63
Are human P[14] rotavirus strains the result of interspecies transmissions from sheep or other ungulates that belong to the mammalian order Artiodactyla? J Virol (2009) 1.62
Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission. J Virol (2006) 1.61
Antibiotics for both moderate and severe cholera. N Engl J Med (2010) 1.59
The effect of rainfall on the incidence of cholera in Bangladesh. Epidemiology (2008) 1.58
Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine (2004) 1.58